Further, the evidence of PIK3C2B log2 expression through DepMap software https://depmap.org/portal/ accessed on 8 April 2021 in different primary and metastatic ovarian cancer cell lines also supports that PIK3C2B is significantly greater in ovarian cancer cell lines (Figure S1G). This evidence concerns the gene PIK3C2B and ovarian carcinoma.